Klinik für Kardiologie
Klinik für Kardiologie / Publikationen
Publikationen mit Koautorschaft im Jahr 2013
Baumgarten A, Bang C, Tschirner A, Engelmann A, Adams V, von Haehling S, Doehner W, Pregla R, Anker MS, Blecharz K, Meyer R, Hetzer R, Anker SD, Thum T, Springer J
TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy.
Int J Cardiol 2013; 168(2): 1447-1452
Berti D, Hendriks JM, Brandes A, Deaton C, Crijns HJ, Camm AJ, Hindricks G, Moons P, Heidbuchel H
A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice.
Eur Heart J 2013; 34(35): 2725-2730
Beschorner U, Krankenberg H, Scheinert D, Sievert H, Tubler T, Sixt S, Noory E, Rastan A, Macharzina R, Zeller T
Rotational and aspiration atherectomy for infrainguinal in-stent restenosis.
Vasa 2013; 42(2): 127-133
Impact factor: 1.009
Bosiers M, Deloose K, Callaert J, Keirse K, Verbist J, Hendriks J, Lauwers P, D\'Archambeau O, Scheinert D, Torsello G, Peeters P
4-French-Compatible Endovascular Material Is Safe and Effective in the Treatment of Femoropopliteal Occlusive Disease: Results of the 4-EVER Trial.
J Endovasc Ther 2013; 20(6): 746-756
Impact factor: 2.699
Bosiers M, Peeters P, Tessarek J, Deloose K, Strickler S
The Zilver® PTX® Single Arm Study: 12-month results from the TASC C/D lesion subgroup.
J Cardiovasc Surg (Torino) 2013; 54(1): 115-122
Impact factor: 1.510
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P
Questionable levels of evidence in new atrial fibrillation guidelines? Reply.
Europace 2013; 15(3): 461-462
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P
\'Patient choice\' concept in AF ESC Guidelines: is the clinician giving up? Reply.
Europace 2013; 15(3): 460-461
Cassese S, Desch S, Kastrati A, Byrne RA, King L, Tada T, Lauer B, Schomig A, Thiele H, Pache J
Polymer-free Sirolimus-eluting Versus Polymer-based Paclitaxel-eluting Stents: An Individual Patient Data Analysis of Randomized Trials.
Rev Esp Cardiol 2013; 66(6): 435-442
Impact factor: 3.204
Cohen AT, Spiro TE, Buller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V
Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
N Engl J Med 2013; 368(6): 513-523
Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Snyder SA, O\'Leary EE, Tepe G, Scheinert D, Zeller T
Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies.
J Am Coll Cardiol 2013; 61(24): 2417-2427
Impact factor: 14.086
Di Mario C, Eltchaninoff H, Moat N, Goicolea J, Ussia GP, Kala P, Wenaweser P, Zembala M, Nickenig G, Alegria Barrero E, Snow T, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludma
The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients.
EuroIntervention 2013; 8(12): 1362-1371
Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, Duvinage A, Stahrenberg R, Durstewitz K, Loffler M, Dungen HD, Tschope C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbric
Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
JAMA 2013; 309(8): 781-791
Gutberlet M, Foldyna B, Grothoff M, Lucke C, Riese F, Nitzsche S, Haensig M, von Aspern K, Holzhey D, Thiele H, Schuler G, Linke A, Mohr FW, Lehmkuhl L
[Imaging prior to transcatheter aortic valve implantation].
Radiologe 2013; 53(10): 886-895
Gutberlet M, Lucke C, Krieghoff C, Hildebrand L, Lurz P, Steiner J, Adam J, Eitel I, Thiele H, Grotthoff M, Lehmkuhl L
[MRI for myocarditis].
Radiologe 2013; 53(1): 30-37
Haensig M, Holzhey DM, Borger MA, Schuler G, Shi W, Subramanian S, Rastan AJ, Mohr FW
Is the new EuroSCORE II a better predictor for transapical aortic valve implantation?
Eur J Cardiothorac Surg 2013; 44(2): 302-8
Haensig M, Holzhey DM, Lehmkuhl L, Lehmann S, Linke A, Schuler G, Girrbach F, Moscoso-Luduena M, Borger MA, Rastan AJ, Mohr FW
Experience with anatomically orientated devices for transapical aortic valve implantation.
Minerva Cardioangiol 2013; 61(1): 33-43
Haensig M, Kiefer P, Linke A, Mukherjee C, Mohr FW, Holzhey DM
Transapical aortic valve-in-valve implantation using a \'partially inflated valvuloplasty balloon\' for valve recovery out of the left ventricle.
Eur Heart J 2013; 34(25): 1884
Haude M, Lee SW, Worthley SG, Silber S, Verheye S, Erbs S, Rosli MA, Botelho R, Meredith I, Sim KH, Stella PR, Tan HC, Whitbourn R, Thambar S, Abizaid A, Koh TH, Den Heijer P, Parise H, Cristea E, Mae
The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent.
JACC Cardiovasc Interv 2013; 6(4): 334-343
Holdt LM, Hoffmann S, Sass K, Langenberger D, Scholz M, Krohn K, Finstermeier K, Stahringer A, Wilfert W, Beutner F, Gielen S, Schuler G, Gabel G, Bergert H, Bechmann I, Stadler PF, Thiery J, Teupser
Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks.
PLoS Genet 2013; 9: 1003588
Ledwoch J, Franke J, Gerckens U, Kuck KH, Linke A, Nickenig G, Krulls-Munch J, Vohringer M, Hambrecht R, Erbel R, Richardt G, Horack M, Zahn R, Senges J, Sievert H
Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: Analysis from the german transcatheter aortic valve interventions registry.
Catheter Cardiovasc Interv 2013; 82(4): 569-577
Lehmkuhl L, Andres C, Lucke C, Hoffmann J, Foldyna B, Grothoff M, Nitzsche S, Schmidt A, Ulrich M, Scheinert D, Gutberlet M
Dynamic CT angiography after abdominal aortic endovascular aneurysm repair: influence of enhancement patterns and optimal bolus timing on endoleak detection.
Radiology 2013; 268(3): 890-899
Impact factor: 6.339
Lehmkuhl L, Foldyna B, Haensig M, von Aspern K, Lucke C, Andres C, Grothoff M, Riese F, Nitzsche S, Holzhey D, Linke A, Mohr FW, Gutberlet M
Role of Preprocedural Computed Tomography in Transcatheter Aortic Valve Implantation.
Rofo 2013; 184(10): 941-949
Lehmkuhl LH, von Aspern K, Foldyna B, Grothoff M, Nitzsche S, Kempfert J, Rastan A, Linke A, Mohr FW, Noettling A, Walther T, Gutberlet M
Comparison of aortic root measurements in patients undergoing transapical aortic valve implantation (TA-AVI) using three-dimensional rotational angiography (3D-RA) and multislice computed tomography (MSCT): differences and variability.
Int J Cardiovasc Imaging 2013; 29(2): 417-424
Lickfett L, Mittmann-Braun E, Weiss C, Spencker S, Jung W, Haverkamp W, Willems S, Deneke T, Kautzner J, Wiedemann M, Siebels J, Pitschner HF, Hoffmann E, Hindricks G, Zabel M, Vester E, Schwacke H, L
Differences in clinical and echocardiographic parameters between paroxysmal and persistent atrial flutter in the AURUM 8 study: targets for prevention of persistent arrhythmia?
Pacing Clin Electrophysiol 2013; 36(2): 194-202
Luscher TF, Gersh B, Hindricks G, Landmesser U, Nallamothu B, Ruschitzka F, Wijns W
The European Heart Journal on the move: can scientific publishing be further improved?
Eur Heart J 2013; 34(6): 409-415
Matsumura JS, Yamanouchi D, Goldstein JA, Pollock CW, Bosiers M, Schultz GA, Scheinert D, Rocha-Singh KJ
The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
J Vasc Surg 2013; 58(1): 73-83
Impact factor: 2.879
McMurray JJ, Anand IS, Diaz R, Maggioni AP, O\'Connor C, Pfeffer MA, Solomon SD, Tendera M, van Veldhuisen DJ, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).
Eur J Heart Fail 2013; 15(3): 334-341
Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Juni P
Percutaneous closure of patent foramen ovale in cryptogenic embolism.
N Engl J Med 2013; 368(12): 1083-1091
Metzner A, Wissner E, Schmidt B, Chun J, Hindricks G, Piorkowski C, Ouyang F, Kuck KH
Acute and long-term clinical outcome after endoscopic pulmonary vein isolation: results from the first prospective, multicenter study.
J Cardiovasc Electrophysiol 2013; 24(1): 7-13
Montalescot G, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay JF, ten Berg JM, Miller DL, Costigan TM, Goedicke J, Silvain J, Angioli P, Legutko J, Niethammer M, Motovska Z, Jakubowski JA, Cayla G
Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes.
N Engl J Med 2013; 369(11): 999-1010
Morice MC, Urban P, Greene S, Schuler G, Chevalier B
Why are we still using coronary bare-metal stents?
J Am Coll Cardiol 2013; 61(10): 1122-1123
Nienaber CA, Kische S, Rousseau H, Eggebrecht H, Rehders TC, Kundt G, Glass A, Scheinert D, Czerny M, Kleinfeldt T, Zipfel B, Labrousse L, Fattori R, Ince H
Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial.
Circ Cardiovasc Interv 2013; 6(4): 407-416
Impact factor: 6.543
Oberbach A, Jehmlich N, Schlichting N, Heinrich M, Lehmann S, Wirth H, Till H, Stolzenburg JU, Volker U, Adams V, Neuhaus J
Molecular fingerprint of high fat diet induced urinary bladder metabolic dysfunction in a rat model.
PLoS One 2013; 8(6): 66636
Onuma Y, Thuesen L, van Geuns RJ, van der Ent M, Desch S, Fajadet J, Christiansen E, Smits P, Ramsing Holm N, Regar E, van Mieghem N, Borovicanin V, Paunovic D, Senshu K, van Es GA, Muramatsu T, Lee I
Randomized study to assess the effect of thrombus aspiration on flow area in patients with ST-elevation myocardial infarction: an optical frequency domain imaging study--TROFI trial.
Eur Heart J 2013; 34(14): 1050-1060
Punkt K, Kandt K, Oberbach A, Adams V, Buchwalow I, Bluher M
Nitric oxide synthase in skeletal muscle fibers of patients with type 2 diabetes.
Acta Histochem 2013; 115(4): 389-393
Rastan A, Krankenberg H, Baumgartner I, Blessing E, Muller-Hulsbeck S, Pilger E, Scheinert D, Lammer J, Gissler M, Noory E, Neumann FJ, Zeller T
Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial.
Circulation 2013; 127(25): 2535-2541
Impact factor: 15.202
Reddy VY, Mobius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H
Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
J Am Coll Cardiol 2013; 61(25): 2551-2556
Roy DA, Schaefer U, Guetta V, Hildick-Smith D, Mollmann H, Dumonteil N, Modine T, Bosmans J, Petronio AS, Moat N, Linke A, Moris C, Champagnac D, Parma R, Ochala A, Medvedofsky D, Patterson T, Woitek
Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation.
J Am Coll Cardiol 2013; 61(15): 1577-1584
Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J, Dickstein K, Ford I, Gorcsan J 3rd, Gras D, Krum H, Sogaard P, Holzmeister J
Cardiac-resynchronization therapy in heart failure with a narrow QRS complex.
N Engl J Med 2013; 369(15): 1395-1405
Schlitt A, Rubboli A, Lip GY, Lahtela H, Valencia J, Karjalainen PP, Weber M, Laine M, Kirchhof P, Niemela M, Vikman S, Buerke M, Airaksinen KE
The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the atrial fibrillation undergoing coronary artery stenting study.
Catheter Cardiovasc Interv 2013; 82(7): 864-870
Impact factor: 2.514
Schwindt A, Reimers B, Scheinert D, Selmon M, Pigott JP, George JC, Robertson G, Janzer S, McDaniel HB, Shrikhande GV, Torsello G, Schaefers J, Sacca S, Versaci F
Crossing chronic total occlusions with the Ocelot system: the initial European experience.
EuroIntervention 2013; 9(7): 854-862
Impact factor: 3.173
Serruys PW, Farooq V, Kalesan B, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, Rademaker-Havinga T, van Es GA
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
JACC Cardiovasc Interv 2013; 6(8): 777-789
Staubach S, Franke J, Gerckens U, Schuler G, Zahn R, Eggebrecht H, Hambrecht R, Sack S, Richardt G, Horack M, Senges J, Steinberg DH, Ledwoch J, Fichtlscherer S, Doss M, Wunderlich N, Sievert H
Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry.
Catheter Cardiovasc Interv 2013; 81(2): 348-355
Sternick EB, Lokhandwala Y, Timmermans C, Gerken L, Soares F, Dias L, Huo Y, Hindricks G, Wellens HJ
Atrial premature beats during decrementally conducting antidromic tachycardia.
Circ Arrhythm Electrophysiol 2013; 6(2): 357-363
Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ
Treatment of anemia with darbepoetin alfa in systolic heart failure.
N Engl J Med 2013; 368(13): 1210-1219
Terkelsen CJ, Pinto D, Clemmensen P, Thiele H, Lassen JF, Christiansen EH, Tilsted Hansen HH, Stankovic G, Olivecrona G, Junker A, Botker HE, Boersma E
A response to a misrepresentation of the STEMI guidelines: the response.
Heart 2013; 99(23): 1787-1788
Impact factor: 5.014
Terkelsen CJ, Pinto DS, Thiele H, Clemmensen P, Nikus K, Lassen JF, Hildick-Smith D, Christiansen EH, Aaroe J, Hansen HH, Stankovic G, Junker A, Sianos G, Olivecrona G, Botker HE, Gibson CM, Boersma E
2012 ESC STEMI guidelines and reperfusion therapy: Evidence base ignored, threatening optimal patient management.
Heart 2013; 99(16): 1154-1156
Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schul
[Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)].
G Ital Cardiol (Rome) 2013; 14(3): 167-214
Wendler O, Walther T, Schroefel H, Lange R, Treede H, Fusari M, Rubino P, Thomas M
Transapical aortic valve implantation: mid-term outcome from the SOURCE registry.
Eur J Cardiothorac Surg 2013; 43(3): 505-11
Zahn R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R, Sack S, Abdel-Wahab M, Hoffmann E, Schiele R, Schneider S, Senges J
Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis.
Am J Cardiol 2013; 112(2): 272-279
Zahn R, Schiele R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R, Sack S, Abdel-Wahab M, Hoffmann E, Senges J
Transcatheter Aortic Valve Implantation in Patients With "Porcelain" Aorta (from a Multicenter Real World Registry).
Am J Cardiol 2013; 111(4): 602-608
Zeller T, Schmidt A, Rastan A, Noory E, Brechtel K, Sixt S, Scheinert D, Tepe G
New approach to protected percutaneous transluminal angioplasty in the lower limbs.
J Endovasc Ther 2013; 20(3): 409-419
Impact factor: 2.699
 10.04.2024 -
Kongress-Update ACC 2024
Klinik für Kardiologie